Channel Button

There are 7 articles on this title. You are reading the article ranked and rated #1 by Helium's members.

Debate_icon

Politics, News & Issues   >

Political Issues

Should pharmaceutical companies be required to give up patents necessary to developing a vaccine against pandemic flu?

Title endorsed in part by:

Results so far:

Yes
72% 28 votes Total: 39 votes
No
28% 11 votes

Pharmaceutical patents need not hinder the development of a vaccine against pandemic flu. There should be a public health law that is essentially equivalent to the right of eminent domain for the building of public works. Even if there isn't such a law the patent holders should agree to this in principle. Certainly they wouldn't want to obstruct the development of such important work.

This law should basically limit a patentee's rights so that they should not unreasonably prevent necessary measures to protect the public health. Some reasonable compensation should be included so that the patent holder receives something for their inventive efforts, but being a patent holder myself, I believe that this should probably apply generally to all patents.

Often times using a patented technology will strengthen it rather than weaken it. This serves to test a technology and by showing where and how it is useful the technology may often gain a competitive advantage over another technology. This is too often under appreciated in the patents that impinge upon the health care and pharmaceutical sectors. There are several other reasons why patented technology is often hidden, but some of them involve very complex methods that companies chose to control their intellectual property (IP). In addition, many companies also hide their technology because of its defects and because they don't want it to be tested by their competitors.

These may be valid reasons to protect a company's IP, but there are circumstances that should require a company or individual patent holder to accept some compensation so that their patented technology can be developed for treating global disasters. Patents are public knowledge once they become registered so it isn't like they are not available. Anyone can look up a patent at the various databases for the U.S. and the world. So companies often need something more than a patent to give them a competitive edge. These extra protections may involve things such as market share, brand recognition and trade secrets.

In general, patent holders are protected if others use their patented technology for commercial gain, since the patent holder can sue them for several times their profits. Of course for the smaller patent holder this may not be feasible if it is going to involve them in a million dollar lawsuit, but for the large corporations this should not be an issue. Big business exercises many restrictive holds over their patented technology for competitive purposes, but this should not restrict the rights of academicians and the scientists in the national health care sectors from being able to do their best to prevent national or international health disasters.

Learn more about this author, Richard G. Lanzara.
Contact this writer Click here to send this author comments or questions.


Below are the top articles rated and ranked by Helium members on:

Should pharmaceutical companies be required to give up patents necessary to developing a vaccine against pandemic flu?

Yes
No
  • 1 of 3

    by P. H. Campbell

    Inasmuch as the profit motive in the medical field raises the hackles of those who believe it should be motivated pur...read more

  • 2 of 3

    by David Thornton

    When considering whether pharmaceutical companies should be required to give up patents necessary to develop a vaccin...read more

Add your voice

Know something about Should pharmaceutical companies be required to give up patents necessary to developing a vaccine against pandemic flu??
We want to hear your view. Write_penWrite now!

What is Helium? | User Guide | Community | Helium’s Official Blog | Link to Helium | Privacy | User agreement | DMCA

Helium, Inc.
200 Brickstone Square Andover, MA 01810 USA